VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function

Eleni Tzima1, John S Reader, Mohamad Irani-Tehrani

  • 1Skaggs Institute for Chemical Biology, Department of Chemistry and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA. etzima@scripps.edu

Insights

A fragment of human tryptophanyl-tRNA synthetase (T2-TrpRS) inhibits new blood vessel formation by binding to VE-cadherin on endothelial cells. This interaction blocks key signaling pathways, revealing a novel anti-angiogenic mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The enzyme fragment human tryptophanyl-tRNA synthetase (T2-TrpRS) exhibits anti-angiogenic properties.
  • The specific cellular receptor mediating T2-TrpRS anti-angiogenic activity was previously unknown.

Purpose of the Study:

  • To identify the cellular receptor for T2-TrpRS.
  • To elucidate the mechanism by which T2-TrpRS inhibits angiogenesis.

Main Methods:

  • Investigated T2-TrpRS binding to endothelial cells (ECs).
  • Utilized genetic knock-outs to determine the role of VE-cadherin and PECAM-1 in T2-TrpRS binding.
  • Performed pull-down assays to confirm direct complex formation.
  • Assessed the impact of T2-TrpRS binding on VEGF-induced ERK activation and EC migration.

Main Results:

  • T2-TrpRS binds to intercellular junctions of ECs.
  • Binding is dependent on VE-cadherin, an EC-specific adhesion molecule, but not PECAM-1.
  • Direct complex formation between T2-TrpRS and VE-cadherin was confirmed.
  • T2-TrpRS binding inhibited VEGF-induced ERK activation and EC migration.

Conclusions:

  • VE-cadherin serves as the cellular receptor for T2-TrpRS on ECs.
  • A VE-cadherin-dependent pathway links T2-TrpRS to the inhibition of angiogenesis.
  • T2-TrpRS represents a novel therapeutic target for anti-angiogenic strategies.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This diversity of cadherins...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...